Back to today’s briefing

Story perspectives

UCLA Study Links Genetics to Weight-Loss Drug Responses

3/28/2026

43 8 Full Breakdown

Summary

Story summary

A UCLA Health study published in Cell shows genetics can predict patient responses to GLP-1 weight-loss drugs.
Researchers analyzed genetic data from 93,936 participants in the ATLAS Community Health Initiative Biobank.
The results show predictive responses vary across ancestry groups.
The study also identifies new genetic links to diseases in specific populations, such as peripheral vascular disease in African individuals.

1 of 1

Story summary

A UCLA Health study published in Cell shows genetics can predict patient responses to GLP-1 weight-loss drugs.
Researchers analyzed genetic data from 93,936 participants in the ATLAS Community Health Initiative Biobank.
The results show predictive responses vary across ancestry groups.
The study also identifies new genetic links to diseases in specific populations, such as peripheral vascular disease in African individuals.